Medical Device Company Semler Scientific and its former distributor Bard Peripheral Vascular Inc. recently reached a $37 million settlement with DOJ to resolve allegations raised by two whistleblowers that they violated the False Claims Act (FCA). Of the almost $37 million settlement, Semler will pay $29.7 million and Bard will pay $7.2 million. The qui […]
